Drug Shortage Report for DEXAMETHASONE-OMEGA

Last updated on 2019-08-30 History
Report ID 87876
Drug Identification Number 02204274
Brand name DEXAMETHASONE-OMEGA
Common or Proper name Dexamethasone Sodium Phosphate Injection USP
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE PHOSPHATE
Strength(s) 10MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 1mL vial / fiole
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-28
Estimated end date 2019-08-12
Actual end date 2019-08-19
Shortage status Resolved
Updated date 2019-08-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-08-30 French Compare
v6 2019-08-30 English Compare
v5 2019-07-19 French Compare
v4 2019-07-19 English Compare
v3 2019-06-29 English Compare
v2 2019-06-28 French Compare
v1 2019-06-28 English Compare

Showing 1 to 7 of 7